Please Wait.....
Report
Head and Neck Cancer Therapeutics - A Global Market Overview
Market Report I 2024-11-05 I 301 Pages I Industry Experts
Head and Neck Cancer Therapeutics Market Trends and Outlook
Head and neck cancer encompasses a diverse group of malignancies that develop in specific regions of the head and neck, including the lips, oral cavity (mouth), nasal cavity, pharynx (throat), larynx (voice box), salivary glands, and paranasal sinuses. These cancers are squamous cell carcinomas that usually begin from the flat cells lining the mucosal surfaces of these regions. Risk factors contributing to the development of these cancers include tobacco use (both smoking and chewing), excessive alcohol consumption, and infection with human papillomavirus (HPV). Identifying the condition can be challenging due to mild symptoms that may mimic less severe ailments, such as persistent sores that do not heal, red or white patches in the mouth, an enduring sore throat, and hoarseness. Timely detection is crucial for effective treatment, which usually involves physical examinations, endoscopic assessments, imaging, and laboratory tests.
Therapies commonly employed for head and neck cancer include immunotherapy, which enhances the body's immune response to destroy cancer cells; targeted therapy, which uses medications to specifically inhibit molecules like the epidermal growth factor receptor (EGFR) that contribute to cancer progression; and chemotherapy, a traditional treatment that employs powerful drugs to kill or slow the growth of cancer cells. Treatment plans vary based on factors such as the cancer's location and stage, the patient's age, and overall health, underscoring the necessity for tailored approaches, as different cancer types respond uniquely to treatments. The global market for Head and Neck Cancer Therapeutics is estimated at US$1.7 billion in 2024 and is anticipated to post a CAGR of 9.4% during the 2024-2030 analysis period and stand at a projected US$3 billion by 2030.
head-and-neck-cancer-therapeutics-market
The head and neck cancer market is primarily driven by increased research and development, which leads to the approval of new drugs, particularly for immunotherapy, targeted therapy, and chemotherapy. Healthcare providers are developing effective treatment options for several types of head and neck cancers, as evidenced by FDA approvals for drugs like Cetuximab and Docetaxel. Market growth is also driven by the rising incidence of HPV infections and increased consumption of alcohol and tobacco, which contribute to the prevalence of head and neck cancers. Additionally, advancements in diagnostic techniques allow for earlier detection, thereby improving treatment outcomes and increasing demand. Nevertheless, the market faces challenges such as high treatment costs limiting access for low- and middle-income patients, as well as adverse side effects like neuropathy and fatigue. Treatment resistance, where cancer cells evade therapies, and lengthy regulatory approval processes further impede market growth.
Head and Neck Cancer Therapeutics Regional Market Analysis
In 2024, North America led the global head and neck cancer therapeutics market, holding an estimated 46.8% market share. Growth in this region is attributed to its advanced healthcare infrastructure, strong awareness of the disease, substantial investments in research and development, and favorable reimbursement policies. The region's dominant position is supported by its robust healthcare system and the high incidence of head and neck cancer associated with tobacco, alcohol, and HPV. Conversely, the Asia Pacific region is expected to witness substantial growth with a CAGR of 10.9% during the forecast period 2024-2030, driven by the increasing number of head and neck cancer cases due to alcohol and tobacco use, growing consumer awareness, and higher healthcare spending. Market expansion in this region is further stimulated by the improving healthcare infrastructure, aging population, and rising disposable incomes. Countries such as China and India are particularly affected by a high prevalence of cancer, influenced by lifestyle factors and government efforts to improve cancer care.
head-and-neck-cancer-therapeutics-market by region
Head and Neck Cancer Therapeutics Market Analysis by Drug Class
Programmed Cell Death (PD) Inhibitors dominate the head and neck cancer therapeutics market with an estimated share of 42.1% in 2024 and is projected to be the fastest-growing therapeutic class, with a CAGR of 10.5% during the analysis period 2024-2030. These inhibitors have shown promising results in improving survival rates and extending progression-free survival, especially in patients with advanced or recurrent cancer. Due to their effectiveness, there is increasing demand for both monotherapy and combination treatments. Current clinical trials are focused on improving treatment approaches, identifying relevant biomarkers, and exploring new combinations.
Head and Neck Cancer Therapeutics Market Analysis by Treatment Type
Immunotherapy is the largest market in the head and neck cancer therapeutics market, holding a share of 43.6% in 2024, and is projected to record the fastest CAGR of 10.7% during the analysis period 2024-2030. By utilizing the body's immune system to target cancer cells, immunotherapy presents promising treatment options for advanced or recurring head and neck cancers, with Pembrolizumab established as a primary therapy. Growth in this sector is expected due to increased patient awareness and the active involvement of the FDA and EMA in approving new formulations. Targeted therapy held the second-largest market share at 22% in 2024, concentrating on specific molecular changes in tumors by interrupting critical signaling pathways. The active participation of companies and healthcare organizations further bolsters the expansion of targeted therapies.
Head and Neck Cancer Therapeutics Market Analysis by Route of Administration
The injectable segment dominated the head and neck cancer therapeutics market in 2024, with a 67.4% share. This dominance is attributed to the effectiveness of various cancer medications, such as chemotherapy and immunotherapy, administered intravenously or through injectables to ensure better absorption and efficacy. Injectable drugs like Cisplatin are notable for their controlled delivery and improved formulations, enhancing treatment efficacy. Conversely, oral administration is anticipated to be the fastest-growing segment, with a CAGR of 10.4% during the forecast period 2024-2030, driven by advancements in oral chemotherapy formulations and patient preferences for convenient at-home treatment options. Oral medications provide flexible treatment schedules, reduce clinic visits, and contribute to personalized head and neck cancer treatment strategies, improving patients' overall quality of life.
head-and-neck-cancer-therapeutics-market by administration route
Head and Neck Cancer Therapeutics Market Analysis by End-User
In 2024, hospitals dominate the head and neck cancer therapeutics end-user market, holding an estimated share of 49.1% due to their well-equipped infrastructure and advanced disease diagnosis capabilities. On the other hand, the Ambulatory Surgical Centers (ASCs) segment is anticipated to register the fastest CAGR of 10.9% during the analysis period from 2024 to 2030, propelled by the increasing demand for cost-effective outpatient surgical treatments and technological progress enabling complex procedures in ASCs. Additionally, this growth is further driven by the rising prevalence of the disease and the necessity for faster treatment options.
Head and Neck Cancer Therapeutics Market Report Scope
This global report on Head and Neck Cancer Therapeutics analyzes the market based on drug class, treatment type, route of administration, and end-users. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.
Key Metrics
Historical Period: 2021-2023
Base Year: 2023
Forecast Period: 2024-2030
Units: Value market in US$
Companies Mentioned: 10+
Head and Neck Cancer Therapeutics Market by Geographic Region
North America (The United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe)
Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
South America (Brazil, Argentina, and Rest of South America)
Rest of World
Head and Neck Cancer Therapeutics Market by Drug Class
Programmed Cell Death (PD) Inhibitors
Microtubule Inhibitors
Epidermal Growth Factor Receptor (EGFR) Inhibitors
Head and Neck Cancer Therapeutics Market by Treatment Type
Immunotherapy
Targeted Therapy
Chemotherapy
Radiation Therapy
Surgery
Head and Neck Cancer Therapeutics Market by Route of Administration
Injectable
Oral
Head and Neck Cancer Therapeutics Market by End-User
Hospitals
Specialty Clinics
Ambulatory Surgical Centers (ASCs)
PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION
- Product Outline
- Head and Neck Cancer Therapeutics Defined
- Head and Neck Cancer Therapeutic Drug Classes
o Programmed Cell Death (PD) Inhibitors
o Microtubule Inhibitors
o Epidermal Growth Factor Receptor (EGFR) Inhibitors
- Head and Neck Cancer Therapeutic Treatment Types
o Immunotherapy
o Targeted Therapy
o Chemotherapy
o Radiation Therapy
o Surgery
- Head and Neck Cancer Therapeutic Route of Administration
o Injectable
o Oral
- Head and Neck Cancer Therapeutic End-Users
o Hospitals
o Specialty Clinics
o Ambulatory Surgical Centers (ASCs)
2. Key Market Trends
3. Key Global Players
- AbbVie Inc.
- AstraZeneca plc
- Bayer AG
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
- Teva Pharmaceutical Industries Ltd.
4. Key Business & Product Trends
5. Global Market Overview
- Global Head and Neck Cancer Therapeutics Market Overview by Drug Class
o Head and Neck Cancer Therapeutics Drug Class Market Overview by Global Region
- Programmed Cell Death (PD) Inhibitors
- Microtubule Inhibitors
- Epidermal Growth Factor Receptor (EGFR) Inhibitors
- Global Head and Neck Cancer Therapeutics Market Overview by Treatment Type
o Head and Neck Cancer Therapeutics Treatment Type Market Overview by Global Region
- Immunotherapy
- Targeted Therapy
- Chemotherapy
- Radiation Therapy
- Surgery
- Global Head and Neck Cancer Therapeutics Market Overview by Route of Administration
o Head and Neck Cancer Therapeutics Route of Administration Market Overview by Global Region
- Injectable
- Oral
- Global Head and Neck Cancer Therapeutics Market Overview by End-User
o Head and Neck Cancer Therapeutics End-User Market Overview by Global Region
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)?
PART B: REGIONAL MARKET PERSPECTIVE
Global Head and Neck Cancer Therapeutics Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America
- North American Head and Neck Cancer Therapeutics Market Overview by Geographic Region
- North American Head and Neck Cancer Therapeutics Market Overview by Drug Class
- North American Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- North American Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- North American Head and Neck Cancer Therapeutics Market Overview by End-User
- Country-wise Analysis of North American Head and Neck Cancer Therapeutics Market
o The United States
- United States Head and Neck Cancer Therapeutics Market Overview by Drug Class
- United States Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- United States Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- United States Head and Neck Cancer Therapeutics Market Overview by End-User
o Canada
- Canadian Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Canadian Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Canadian Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Canadian Head and Neck Cancer Therapeutics Market Overview by End-User
o Mexico
- Mexican Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Mexican Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Mexican Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Mexican Head and Neck Cancer Therapeutics Market Overview by End-User
7. Europe
- European Head and Neck Cancer Therapeutics Market Overview by Geographic Region
- European Head and Neck Cancer Therapeutics Market Overview by Drug Class
- European Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- European Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- European Head and Neck Cancer Therapeutics Market Overview by End-User
- Country-wise Analysis of European Head and Neck Cancer Therapeutics Market
o Germany
- German Head and Neck Cancer Therapeutics Market Overview by Drug Class
- German Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- German Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- German Head and Neck Cancer Therapeutics Market Overview by End-User
o France
- French Head and Neck Cancer Therapeutics Market Overview by Drug Class
- French Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- French Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- French Head and Neck Cancer Therapeutics Market Overview by End-User
o The United Kingdom
- United Kingdom Head and Neck Cancer Therapeutics Market Overview by Drug Class
- United Kingdom Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- United Kingdom Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- United Kingdom Head and Neck Cancer Therapeutics Market Overview by End-User
o Italy
- Italian Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Italian Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Italian Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Italian Head and Neck Cancer Therapeutics Market Overview by End-User
o Spain
- Spanish Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Spanish Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Spanish Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Spanish Head and Neck Cancer Therapeutics Market Overview by End-User
o Rest of Europe
- Rest of Europe Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Rest of Europe Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Rest of Europe Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Rest of Europe Head and Neck Cancer Therapeutics Market Overview by End-User
8. Asia-Pacific
- Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Geographic Region
- Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by End-User
- Country-wise Analysis of Asia-Pacific Head and Neck Cancer Therapeutics Market
o Japan
- Japanese Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Japanese Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Japanese Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Japanese Head and Neck Cancer Therapeutics Market Overview by End-User
o China
- Chinese Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Chinese Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Chinese Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Chinese Head and Neck Cancer Therapeutics Market Overview by End-User
o India
- Indian Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Indian Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Indian Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Indian Head and Neck Cancer Therapeutics Market Overview by End-User
o South Korea
- South Korean Head and Neck Cancer Therapeutics Market Overview by Drug Class
- South Korean Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- South Korean Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- South Korean Head and Neck Cancer Therapeutics Market Overview by End-User
o Rest of Asia-Pacific
- Rest of Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Rest of Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Rest of Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Rest of Asia-Pacific Head and Neck Cancer Therapeutics Market Overview by End-User
9. South America
- South American Head and Neck Cancer Therapeutics Market Overview by Geographic Region
- South American Head and Neck Cancer Therapeutics Market Overview by Drug Class
- South American Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- South American Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- South American Head and Neck Cancer Therapeutics Market Overview by End-User
- Country-wise Analysis of Asia-Pacific Head and Neck Cancer Therapeutics Market
o Brazil
- Brazilian Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Brazilian Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Brazilian Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Brazilian Head and Neck Cancer Therapeutics Market Overview by End-User
o Argentina
- Argentine Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Argentine Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Argentine Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Argentine Head and Neck Cancer Therapeutics Market Overview by End-User
o Rest of South America
- Rest of South American Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Rest of South American Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Rest of South American Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Rest of South American Head and Neck Cancer Therapeutics Market Overview by End-User
10. Rest of World
- Rest of World Head and Neck Cancer Therapeutics Market Overview by Drug Class
- Rest of World Head and Neck Cancer Therapeutics Market Overview by Treatment Type
- Rest of World Head and Neck Cancer Therapeutics Market Overview by Route of Administration
- Rest of World Head and Neck Cancer Therapeutics Market Overview by End-User
PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security